Trilobio has introduced a comprehensive automation platform that combines robotics, laboratory equipment and protocol software, designed to enhance reproducibility in life science research. Pilot data demonstrates significant improvements in throughput and data production for genetic engineering and synthetic biology applications.
THE LABORATORY R&D INDUSTRY EXHIBITION DEDICATED TO RESEARCH, PRODUCTION, CONTROL AND PROCESS
Wren Laboratories has officially discontinued their original NETest 1.0 in favour of an AI-enhanced successor. The new liquid biopsy diagnostic offers improved sensitivity and accuracy for monitoring neuroendocrine tumours through an optimised 51-gene mRNA expression algorithm.
Revvity’s EUROIMMUN has received CE marking for its Anti-Measles Virus ELISA 2.0 (IgG), the first commercial assay validated for dried blood spot (DBS) sample material, addressing a critical gap in measles diagnostics as global cases continue to rise.
by Dr Gard Myrmel We have known for a while now that the symptoms of acute coronary syndromes can be different for women compared to men. Here, Dr Myrmel discusses how the differences between the sexes also extend to the prognostic value of circulating biomarkers in patients presenting with acute chest pain.
Advanced thermal uniformity capabilities Torrey Pines Scientific has unveiled its WaferPlate programmable heating system, designed specifically for precision temperature control applications. The Model HP90 features exceptional thermal uniformity across its 352.4mm circular aluminium surfatce, maintaining temperature consistency within 1% across the central 304mm area.
The revolutionary UV-150 photochemical reactor, employed alongside Vapourtec’s R-Series flow chemistry system, has enabled significant advancements in peptide modification techniques with potential to reshape pharmaceutical manufacturing.
Global healthcare company Sanofi has successfully priced a €1.5 billion bond issue, structured across two tranches with different maturity profiles and interest rate mechanisms. The financing move, announced on 5 March 2025, represents a significant capital raising exercise that strengthens the company’s financial position.
by PD Dr Angelika Hammerer-Lercher Measurement of cardiac-specific troponin I or T forms is part of the diagnostic pathway to rule in or rule out acute coronary syndromes, such as heart attack, as well as for prognostication of future cardiovascular disease. CLI chatted to Dr Angelika Hammerer-Lercher (Chief Physician and Director of Central Medical Laboratories, […]
Thailand Lab International, September 3 – 5, 2025
May 2026
Prins Hendrikstraat 1
5611HH Eindhoven
The Netherlands
info@clinlabint.com
PanGlobal Media is not responsible for any error or omission that might occur in the electronic display of product or company data.